Custom Synthesis

Wms-1410 View larger

Wms-1410

AOB12655

Molarity Calculation Cart®

HOW TO ORDER

$0.00

More info

Novel GluN2B-specific NMDAR antagonist, completely preventing the decrease in insulin secretion of about 32 % provoked by a 24-h-treatment with NMDA/glycine, eliminating NMDA-induced changes in the oxidation status of the islet cells and elevating the sensitivity of intracellular calciumto 15 mM glucose